ALT - SA Asks: Which weight-loss stocks should investors be watching?
2024-06-02 10:00:00 ET
More on Amgen, Structure Therapeutics, etc.
- Novo Nordisk: The Market Is Right, Don't Fight Against It
- Novo Nordisk: Not The Best Investment Right Now, But A Great Case Study
- Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe?
- Pfizer posts long-term data to support lung cancer therapy Lorbrena
- Pfizer gene therapy for haemophilia B therapy endorsed in EU